Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:1606-1612

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, E. P.
Right arrow Articles by Van Trigt, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, E. P.
Right arrow Articles by Van Trigt, P.

(Circulation. 1998;97:1606-1612.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Pharmacological Strategies for Improving Diastolic Dysfunction in the Setting of Chronic Pulmonary Hypertension

Edward P. Chen, MD; Damian M. Craig, MS; Hartmuth B. Bittner, MD, PhD; R. Duane Davis, MD; ; Peter Van Trigt, MD

From the Department of Surgery, Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, NC.

Background—Right ventricular (RV) hypertrophy is an adaptive process that occurs in the setting of chronic pulmonary hypertension (CPH) and can lead to alterations in normal RV diastolic properties. This study was designed to investigate the effects of NO and milrinone on RV diastolic dysfunction in the setting of CPH and RV hypertrophy by use of a canine model of monocrotaline pyrrole (MCTP)–induced CPH.

Methods and Results—Sixteen mongrel dogs (22 to 24 kg) were used. Animals underwent percutaneous pulmonary artery (PA) catheterization to measure pulmonary hemodynamics before and 8 weeks after injection of 3 mg/kg MCTP (n=8) or placebo (control, n=8). Eight weeks after injection, all hearts were instrumented with a PA flow probe, sonomicrometric dimension transducers, and micromanometers. Data were collected at baseline and after both NO and milrinone administration. Diastolic properties were quantified by use of the end-diastolic pressure-volume relationship and the time constant of ventricular isovolumic relaxation. Eight weeks after injection, significant increases in the PA pressure and pulmonary vascular resistance were observed in MCTP dogs. Significant worsening of RV diastolic function occurred in association with significant increases in the ratio of RV dry weight to LV+septal dry weight. NO and milrinone administration both led to significant improvements in RV diastolic properties.

Conclusions—In the setting of MCTP-induced CPH, significant worsening of RV diastolic function was observed in association with significant increases in the ratio of RV dry weight to LV+septal dry weight, suggesting that these changes are partially due to RV hypertrophy. The significant improvement in RV diastolic properties after both NO and milrinone administration suggests that these agents may be effective forms of pharmacological therapy for improving RV diastolic dysfunction in the setting of CPH.


Key Words: hypertension, pulmonary • diastole • ventricles • hypertrophy




This article has been cited by other articles:


Home page
ChestHome page
S. M. Kawut, N. Al-Naamani, C. Agerstrand, E. Berman Rosenzweig, C. Rowan, R. J. Barst, S. Bergmann, and E. M. Horn
Determinants of Right Ventricular Ejection Fraction in Pulmonary Arterial Hypertension
Chest, March 1, 2009; 135(3): 752 - 759.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Zierer, S. J. Melby, R. K. Voeller, and M. R. Moon
Interatrial shunt for chronic pulmonary hypertension: differential impact of low-flow vs. high-flow shunting
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H639 - H644.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. T.-J. Gan, S. Holverda, J. T. Marcus, W. J. Paulus, K. M. Marques, J. G.F. Bronzwaer, J. W. Twisk, A. Boonstra, P. E. Postmus, and A. Vonk-Noordegraaf
Right Ventricular Diastolic Dysfunction and the Acute Effects of Sildenafil in Pulmonary Hypertension Patients
Chest, July 1, 2007; 132(1): 11 - 17.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Y. Denault, Y. Lamarche, P. Couture, F. Haddad, J. Lambert, J.-C. Tardif, and L. P. Perrault
Inhaled milrinone: a new alternative in cardiac surgery?
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 346 - 360.
[Abstract] [PDF]


Home page
CirculationHome page
N. F. Voelkel, R. A. Quaife, L. A. Leinwand, R. J. Barst, M. D. McGoon, D. R. Meldrum, J. Dupuis, C. S. Long, L. J. Rubin, F. W. Smart, et al.
Right Ventricular Function and Failure: Report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure
Circulation, October 24, 2006; 114(17): 1883 - 1891.
[Full Text] [PDF]


Home page
CirculationHome page
S. L. Gaynor, H. S. Maniar, J. B. Bloch, P. Steendijk, and M. R. Moon
Right Atrial and Ventricular Adaptation to Chronic Right Ventricular Pressure Overload
Circulation, August 30, 2005; 112(9_suppl): I-212 - I-218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. P. J. Leeuwenburgh, P. Steendijk, W. A. Helbing, and J. Baan
Indexes of diastolic RV function: load dependence and changes after chronic RV pressure overload in lambs
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1350 - H1358.
[Abstract] [Full Text] [PDF]